Inhibition of multidrug resistance protein 1 (MRP1) improves chemotherapy drug response in primary and recurrent glioblastoma multiforme

por Tivnan, Amanda, Zakaria, Zaitun, O'Leary, Caitrín, Kögel, Donat, Pokorny, Jenny L., Sarkaria, Jann N., Prehn, Jochen H. M.
Publicado 2015

Network Modeling Identifies Patient-specific Pathways in Glioblastoma

por Tuncbag, Nurcan, Milani, Pamela, Pokorny, Jenny L., Johnson, Hannah, Sio, Terence T., Dalin, Simona, Iyekegbe, Dennis O., White, Forest M., Sarkaria, Jann N., Fraenkel, Ernest
Publicado 2016

Anti-GD2-ch14.18/CHO coated nanoparticles mediate glioblastoma (GBM)-specific delivery of the aromatase inhibitor, Letrozole, reducing proliferation, migration and chemoresistance...

por Tivnan, Amanda, Heilinger, Tatjana, Ramsey, Joanne M, O’Connor, Gemma, Pokorny, Jenny L, Sarkaria, Jann N, Stringer, Brett W, Day, Bryan W, Boyd, Andrew W, Kim, Ella L, Lode, Holger N, Cryan, Sally-Ann, Prehn, Jochen H.M
Publicado 2017